Drug intelligence / Profile preview

insulin in dextran matrix

Development stage
Unknown
Lead developer
Bows Pharmaceuticals
Modality
Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

insulin in dextran matrix is an investigational oral insulin formulation developed by Bows Pharmaceuticals AG for the treatment of type 2 diabetes mellitus. The drug consists of human insulin encapsulated within a proprietary dextran-based matrix, which is designed to protect the protein from enzymatic degradation in the stomach and upper gastrointestinal tract. This delivery system facilitates insulin absorption in the small intestine, allowing the hormone to enter the portal circulation and mimic the natural first-pass effect through the liver, potentially offering a more physiological distribution compared to subcutaneous injections. It has been evaluated in Phase 1/2 clinical trials to assess its safety, tolerability, and ability to lower post-prandial blood glucose levels.

Other names
peroral insulin in dextran matrixoral insulin (Bows Pharmaceuticals)
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on insulin in dextran matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on insulin in dextran matrix.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call